Insider · CIK 0001237522

WELCH WILLIAM J

Reports to the SEC for 4 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001237522

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-01-30	CRDFCardiff Oncology, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+130K sh	—	—	904,655
2018-01-30	CRDFCardiff Oncology, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−62K sh	—	—	842,645
2018-01-30	CRDFCardiff Oncology, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−130K sh	—	—	150,000
2018-01-23	CRDFCardiff Oncology, Inc. · Stock OptionsA Award	Director, Chief Executive Officer	AAward	+663K sh	—	—	1,412,500
2018-01-02	CRDFCardiff Oncology, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+50K sh	—	—	800,142
2018-01-02	CRDFCardiff Oncology, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−25.5K sh	—	—	774,655
2018-01-02	CRDFCardiff Oncology, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−50K sh	—	—	280,000
2018-01-02	CRDFCardiff Oncology, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+50K sh	—	—	795,392
2018-01-02	CRDFCardiff Oncology, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−25.5K sh	—	—	769,905
2018-01-02	CRDFCardiff Oncology, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−50K sh	—	—	280,000
2017-08-15	CRDFCardiff Oncology, Inc.A Award	Director, Chief Executive Officer	AAward	+745K sh	—	—	745,392
2017-04-07	CRDFCardiff Oncology, Inc. · Restricted Stock UnitsA Award	Director, Chief Executive Officer	AAward	+130K sh	—	—	330,000
2017-01-02	CRDFCardiff Oncology, Inc. · Restricted Stock UnitsA Award	Director, Chief Executive Officer	AAward	+200K sh	—	—	200,000
2016-12-16	CRDFCardiff Oncology, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+2,500 sh	$2.10	+$5,250	2,500
2016-12-16	CRDFCardiff Oncology, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+2,250 sh	$2.09	+$4,693.5	4,750
2015-06-10	SEQUENOM INCM Exercise/Conversion	President & CEO	MExercise/Conversion	+5,500 sh	—	—	58,127
2015-06-10	SEQUENOM INCF Tax Payment	President & CEO	FTax Payment	−2,067 sh	$3.34	−$6,903.78	56,060
2015-06-10	SEQUENOM INCRestricted Stock UnitM Exercise/Conversion	President & CEO	MExercise/Conversion	−5,500 sh	—	—	258,874
2015-03-10	SEQUENOM INCP Purchase	President & CEO	PPurchase	+10K sh	$3.65	+$36.5K	52,627
2015-02-10	SEQUENOM INCM Exercise/Conversion	President & CEO	MExercise/Conversion	+13.5K sh	—	—	47,701
2015-02-10	SEQUENOM INCF Tax Payment	President & CEO	FTax Payment	−5,074 sh	$3.47	−$17.6K	42,627
2015-02-10	SEQUENOM INCIncentive Stock Option (right to buy)A Award	President & CEO	AAward	+11.2K sh	—	—	11,228
2015-02-10	SEQUENOM INCNon-Qualified Stock Option (right to buy)A Award	President & CEO	AAward	+219K sh	—	—	218,772
2015-02-10	SEQUENOM INCRestricted Stock UnitA Award	President & CEO	AAward	+180K sh	—	—	277,874
2015-02-10	SEQUENOM INCRestricted Stock UnitM Exercise/Conversion	President & CEO	MExercise/Conversion	−13.5K sh	—	—	264,374
2014-12-10	SEQUENOM INCM Exercise/Conversion	President & CEO	MExercise/Conversion	+10.9K sh	—	—	36,874
2014-12-10	SEQUENOM INCF Tax Payment	President & CEO	FTax Payment	−4,111 sh	$3.73	−$15.3K	32,763
2014-12-10	SEQUENOM INCRestricted Stock UnitM Exercise/Conversion	President & CEO	MExercise/Conversion	−10.9K sh	—	—	97,874
2014-02-01	SEQUENOM INCIncentive Stock Option (right to buy)A Award	President & CEO	AAward	+31.5K sh	—	—	31,500
2014-02-01	SEQUENOM INCNon-Qualified Stock Option (right to buy)A Award	President & CEO	AAward	+76.5K sh	—	—	76,500
2014-02-01	SEQUENOM INCRestricted Stock UnitA Award	President & CEO	AAward	+54K sh	—	—	86,812
2013-12-10	SEQUENOM INCA Award	President & CEO	AAward	+10.9K sh	—	—	25,688
2013-12-10	SEQUENOM INCF Tax Payment	President & CEO	FTax Payment	−4,111 sh	$2.34	−$9,619.74	21,577
2013-12-10	SEQUENOM INCRestricted Stock UnitD Disposition to Issuer	President & CEO	DDisposition to Issuer	−10.9K sh	—	—	32,812
2013-06-19	SEQUENOM INCA Award	President & CEO	AAward	+8,833 sh	—	—	16,535
2013-06-19	SEQUENOM INCF Tax Payment	President & CEO	FTax Payment	−3,320 sh	$4.22	−$14K	13,215
2012-12-10	SEQUENOM INCIncentive Stock Option (right to buy)A Award	President & CEO	AAward	+14.2K sh	—	—	14,236
2012-12-10	SEQUENOM INCNon-Qualified Stock Option (right to buy)A Award	President & CEO	AAward	+73.3K sh	—	—	73,264
2012-12-10	SEQUENOM INCRestricted Stock UnitA Award	President & CEO	AAward	+43.8K sh	—	—	43,750
2012-02-07	SEQUENOM INCA Award	President & CEO	AAward	+1,166 sh	—	—	3,248
2012-02-07	SEQUENOM INCA Award	President & CEO	AAward	+1,166 sh	—	—	4,414
2012-02-07	SEQUENOM INCA Award	President & CEO	AAward	+294 sh	—	—	4,708
2012-02-07	SEQUENOM INCIncentive Stock Option (right to buy)A Award	President & CEO	AAward	+88K sh	—	—	87,967
2012-02-07	SEQUENOM INCNon-Qualified Stock Option (right to buy)A Award	President & CEO	AAward	+72K sh	—	—	72,033
2011-07-18	SEQUENOM INCA Award	President & CEO	AAward	+1,458 sh	—	—	1,458
2011-07-18	SEQUENOM INCF Tax Payment	President & CEO	FTax Payment	−534 sh	$7.46	−$3,983.64	924
2009-01-16	Monogram Biosciences, Inc.Stock Option (Rt to Buy)A Award	SVP, Chief Commercial Officer	AAward	+35K sh	—	—	35,000
2009-01-16	Monogram Biosciences, Inc.Stock Option (Rt to Buy)A Award	SVP, Chief Commercial Officer	AAward	+35K sh	—	—	35,000
2005-08-31	Monogram Biosciences, Inc.Stock Option (Right to Buy)A Award	SVP, Chief Commercial Officer	AAward	+300K sh	—	—	300,000
2005-05-19	LA JOLLA PHARMACEUTICAL COStock Option (right to buy)A Award	VP Sales & Marketing	AAward	+33.9K sh	$0.43	+$14.6K	472,500

Recent filings

Accepted (ET)
Feb 14
WELCH WILLIAM J0000899243-18-002485
SEC(opens sec.gov)
Jan 254
WELCH WILLIAM J0000899243-18-001902
SEC(opens sec.gov)
Jan 44/A
WELCH WILLIAM J0000899243-18-000546
SEC(opens sec.gov)
Jan 44
WELCH WILLIAM J0000899243-18-000486
SEC(opens sec.gov)
Aug 174
WELCH WILLIAM J0001104659-17-052470
SEC(opens sec.gov)
Apr 104
Trovagene, Inc.0001104659-17-022530
SEC(opens sec.gov)
Jan 44
Trovagene, Inc.0001104659-17-000634
SEC(opens sec.gov)
Dec 194
Trovagene, Inc.0001104659-16-162787
SEC(opens sec.gov)
Jun 114
SEQUENOM INC0001193614-15-000039
SEC(opens sec.gov)
Mar 114
SEQUENOM INC0001193614-15-000029
SEC(opens sec.gov)
Feb 114
SEQUENOM INC0001193614-15-000023
SEC(opens sec.gov)

Companies

Address

C/O MONOGRAM BIOSCIENCES, INC. 345 OYSTER POINT BOULEVARD

SOUTH SAN FRANCISCO, CA, 94080